Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum

Program Overview

The goal of this activity is to educate physicians and other healthcare professionals on the appropriate management of patients with BCC at different disease stages.

Credit Expired
0.75 CE Credit(s)
Expires: June 14, 2022

Target Audience

This activity is intended for oncology, dermatology, and dermato-oncology clinicians who manage patients with basal cell carcinoma (BCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Distinguish between high- and low-risk BCC
  • Apply the current standard of care for treating high-risk BCC
  • Select appropriate front-line systemic therapy for advanced BCC
  • Evaluate emerging efficacy and safety data for immunotherapy in advanced BCC, offering clinical trial enrollment where appropriate

Activity Faculty

Gutzmer

Prof. Ralf Gutzmer, MD (Chair)

Director
Department of Dermatology
Skin Cancer Center Minden
Johannes-Wesling-Klinikum Minden/Ruhr-University Bochum
Minden, Germany

Bassett

Prof. Nicole Basset-Seguin, MD, PhD

Policlinique de Dermatologie
Hôpital Saint-Louis
Université de Paris
Paris, France

Hamid

Omid Hamid, MD

Chief of Research/Immuno-Oncology
The Angeles Clinic & Research Institute
Co-Director, Cutaneous Malignancy Program
Cedars-Sinai CANCER
Los Angeles, California, United States

Thomas Hunter (Patient)

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources